Bulletin
Investor Alert

Syros Pharmaceuticals Inc.

NAS: SYRS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 4, 2022, 7:55 p.m.

/zigman2/quotes/201168308/composite

$

6.43

Change

-0.21 -3.16%

Volume

Volume 1,658

Quotes are delayed by 20 min

/zigman2/quotes/201168308/composite

Previous close

$ 5.94

$ 6.64

Change

+0.70 +11.78%

Day low

Day high

$6.16

$6.81

Open

52 week low

52 week high

$5.25

$48.00

Open

Richard A. Young

Founder of Syros Pharmaceuticals, Inc. and Camp4 Therapeutics Corp., Richard A. Young is on the board of Syros Pharmaceuticals, Inc., Camp4 Therapeutics Corp., Omega Therapeutics, Inc. and Dewpoint Therapeutics, Inc. and Professor at Massachusetts Institute of Technology and Member of Whitehead Institute for Biomedical Research.

In his past career Dr. Young was Senior Vice President-Steel Mill Product Sales at Eastern Alloys, Inc.

He received a doctorate from Yale University and an undergraduate degree from Indiana University.

Transactions

Date Shares Transaction Value
02/16/2021 3,750   Disposition at $12.05 per share. 45,188
02/08/2021 3,750   Disposition at $13.04 per share. 48,900
11/17/2020 5,357   Disposition at $8.75 per share. 46,874
11/17/2020 5,357   Disposition at $8.75 per share. 46,874
11/16/2020 633   Disposition at $8.98 per share. 5,685
11/16/2020 633   Disposition at $8.98 per share. 5,685
10/19/2020 5,673   Disposition at $8.75 per share. 49,639
10/15/2020 317   Disposition at $8.75 per share. 2,774
09/15/2020 5,990   Disposition at $10.39 per share. 62,237
08/17/2020 5,990   Disposition at $12.59 per share. 75,415
07/15/2020 5,990   Disposition at $11.85 per share. 70,982
06/15/2020 5,990   Disposition at $8.75 per share. 52,413
05/15/2020 5,990   Disposition at $9.22 per share. 55,228
04/15/2020 23,960   Disposition at $8.75 per share. 209,650
08/16/2019 22,700   Disposition at $10 per share. 227,000
08/15/2019 2,300   Disposition at $10 per share. 23,000

Officers and Executives

Dr. Nancy A. Simonian
President, Chief Executive Officer & Director
Mr. Jason Haas
Chief Financial Officer
Dr. Eric R. Olson
Chief Scientific Officer
Dr. David A. Roth
Chief Medical Officer
Ms. Kristin Stephen
Chief Development Officer
Mr. Conley Chee
Chief Commercial Officer
Dr. Richard A. Young
Director
Mr. Peter Wirth
Chairman
Mr. Mark J. Alles
Independent Director
Dr. S. Gail Eckhardt
Independent Director
Dr. Deborah L. Dunsire
Independent Director
Dr. Phillip A. Sharp
Independent Director
Ms. Marsha H. Fanucci
Independent Director
Dr. Amir H. Nashat
Independent Director
Dr. Srinivas Akkaraju
Independent Director
Link to MarketWatch's Slice.